nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—Abdominal bloating—Risedronate—Paget's disease of bone	0.0361	0.0361	CcSEcCtD
Norethindrone—Dermatitis atopic—Risedronate—Paget's disease of bone	0.0232	0.0232	CcSEcCtD
Norethindrone—Neoplasm malignant—Pamidronate—Paget's disease of bone	0.0191	0.0191	CcSEcCtD
Norethindrone—Photosensitivity—Alendronate—Paget's disease of bone	0.0177	0.0177	CcSEcCtD
Norethindrone—Neoplasm malignant—Zoledronate—Paget's disease of bone	0.0175	0.0175	CcSEcCtD
Norethindrone—Dyspepsia—Tiludronate—Paget's disease of bone	0.0165	0.0165	CcSEcCtD
Norethindrone—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.0153	0.0153	CcSEcCtD
Norethindrone—Abdominal pain—Tiludronate—Paget's disease of bone	0.0148	0.0148	CcSEcCtD
Norethindrone—Thrombophlebitis—Pamidronate—Paget's disease of bone	0.0137	0.0137	CcSEcCtD
Norethindrone—Abdominal distension—Alendronate—Paget's disease of bone	0.0135	0.0135	CcSEcCtD
Norethindrone—Asthenia—Tiludronate—Paget's disease of bone	0.0134	0.0134	CcSEcCtD
Norethindrone—Pain in extremity—Risedronate—Paget's disease of bone	0.0125	0.0125	CcSEcCtD
Norethindrone—Dizziness—Tiludronate—Paget's disease of bone	0.0124	0.0124	CcSEcCtD
Norethindrone—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.0123	0.0123	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Pamidronate—Paget's disease of bone	0.0122	0.0122	CcSEcCtD
Norethindrone—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.0119	0.0119	CcSEcCtD
Norethindrone—Headache—Tiludronate—Paget's disease of bone	0.0117	0.0117	CcSEcCtD
Norethindrone—Renal impairment—Zoledronate—Paget's disease of bone	0.0114	0.0114	CcSEcCtD
Norethindrone—Breast disorder—Risedronate—Paget's disease of bone	0.0113	0.0113	CcSEcCtD
Norethindrone—Alopecia—Etidronic acid—Paget's disease of bone	0.0111	0.0111	CcSEcCtD
Norethindrone—Nausea—Tiludronate—Paget's disease of bone	0.0111	0.0111	CcSEcCtD
Norethindrone—Abdominal distension—Risedronate—Paget's disease of bone	0.0108	0.0108	CcSEcCtD
Norethindrone—Pain in extremity—Zoledronate—Paget's disease of bone	0.0108	0.0108	CcSEcCtD
Norethindrone—Flatulence—Etidronic acid—Paget's disease of bone	0.0108	0.0108	CcSEcCtD
Norethindrone—Haemoglobin—Alendronate—Paget's disease of bone	0.0108	0.0108	CcSEcCtD
Norethindrone—Haemorrhage—Alendronate—Paget's disease of bone	0.0107	0.0107	CcSEcCtD
Norethindrone—Erythema multiforme—Alendronate—Paget's disease of bone	0.0102	0.0102	CcSEcCtD
Norethindrone—Depression—Risedronate—Paget's disease of bone	0.00958	0.00958	CcSEcCtD
Norethindrone—Alopecia—Alendronate—Paget's disease of bone	0.00949	0.00949	CcSEcCtD
Norethindrone—Abdominal distension—Zoledronate—Paget's disease of bone	0.00942	0.00942	CcSEcCtD
Norethindrone—Flatulence—Alendronate—Paget's disease of bone	0.00922	0.00922	CcSEcCtD
Norethindrone—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00908	0.00908	CcSEcCtD
Norethindrone—Renal failure—Pamidronate—Paget's disease of bone	0.00897	0.00897	CcSEcCtD
Norethindrone—Haemoglobin—Risedronate—Paget's disease of bone	0.00866	0.00866	CcSEcCtD
Norethindrone—Haemorrhage—Risedronate—Paget's disease of bone	0.00862	0.00862	CcSEcCtD
Norethindrone—Weight increased—Zoledronate—Paget's disease of bone	0.00851	0.00851	CcSEcCtD
Norethindrone—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00847	0.00847	CcSEcCtD
Norethindrone—Depression—Zoledronate—Paget's disease of bone	0.00831	0.00831	CcSEcCtD
Norethindrone—Haemoglobin—Pamidronate—Paget's disease of bone	0.00824	0.00824	CcSEcCtD
Norethindrone—Renal failure—Zoledronate—Paget's disease of bone	0.0082	0.0082	CcSEcCtD
Norethindrone—Haemorrhage—Pamidronate—Paget's disease of bone	0.0082	0.0082	CcSEcCtD
Norethindrone—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00805	0.00805	CcSEcCtD
Norethindrone—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00789	0.00789	CcSEcCtD
Norethindrone—Immune system disorder—Risedronate—Paget's disease of bone	0.00779	0.00779	CcSEcCtD
Norethindrone—Mental disorder—Risedronate—Paget's disease of bone	0.00755	0.00755	CcSEcCtD
Norethindrone—Immune system disorder—Pamidronate—Paget's disease of bone	0.0074	0.0074	CcSEcCtD
Norethindrone—Flatulence—Risedronate—Paget's disease of bone	0.0074	0.0074	CcSEcCtD
Norethindrone—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00736	0.00736	CcSEcCtD
Norethindrone—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00733	0.00733	CcSEcCtD
Norethindrone—Alopecia—Pamidronate—Paget's disease of bone	0.00724	0.00724	CcSEcCtD
Norethindrone—Urticaria—Etidronic acid—Paget's disease of bone	0.00712	0.00712	CcSEcCtD
Norethindrone—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00708	0.00708	CcSEcCtD
Norethindrone—Tension—Pamidronate—Paget's disease of bone	0.007	0.007	CcSEcCtD
Norethindrone—Nervousness—Pamidronate—Paget's disease of bone	0.00693	0.00693	CcSEcCtD
Norethindrone—Immune system disorder—Zoledronate—Paget's disease of bone	0.00676	0.00676	CcSEcCtD
Norethindrone—Dyspepsia—Alendronate—Paget's disease of bone	0.00672	0.00672	CcSEcCtD
Norethindrone—Alopecia—Zoledronate—Paget's disease of bone	0.00661	0.00661	CcSEcCtD
Norethindrone—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.0066	0.0066	CcSEcCtD
Norethindrone—Mental disorder—Zoledronate—Paget's disease of bone	0.00656	0.00656	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00635	0.00635	CcSEcCtD
Norethindrone—Pruritus—Etidronic acid—Paget's disease of bone	0.00634	0.00634	CcSEcCtD
Norethindrone—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00624	0.00624	CcSEcCtD
Norethindrone—Convulsion—Pamidronate—Paget's disease of bone	0.00618	0.00618	CcSEcCtD
Norethindrone—Urticaria—Alendronate—Paget's disease of bone	0.00606	0.00606	CcSEcCtD
Norethindrone—Abdominal pain—Alendronate—Paget's disease of bone	0.00603	0.00603	CcSEcCtD
Norethindrone—Skin disorder—Risedronate—Paget's disease of bone	0.00595	0.00595	CcSEcCtD
Norethindrone—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00582	0.00582	CcSEcCtD
Norethindrone—Oedema—Pamidronate—Paget's disease of bone	0.00582	0.00582	CcSEcCtD
Norethindrone—Vomiting—Etidronic acid—Paget's disease of bone	0.0057	0.0057	CcSEcCtD
Norethindrone—Rash—Etidronic acid—Paget's disease of bone	0.00565	0.00565	CcSEcCtD
Norethindrone—Convulsion—Zoledronate—Paget's disease of bone	0.00565	0.00565	CcSEcCtD
Norethindrone—Dermatitis—Etidronic acid—Paget's disease of bone	0.00564	0.00564	CcSEcCtD
Norethindrone—Hypersensitivity—Alendronate—Paget's disease of bone	0.00562	0.00562	CcSEcCtD
Norethindrone—Headache—Etidronic acid—Paget's disease of bone	0.00561	0.00561	CcSEcCtD
Norethindrone—Insomnia—Risedronate—Paget's disease of bone	0.00554	0.00554	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00551	0.00551	CcSEcCtD
Norethindrone—Asthenia—Alendronate—Paget's disease of bone	0.00548	0.00548	CcSEcCtD
Norethindrone—Pruritus—Alendronate—Paget's disease of bone	0.0054	0.0054	CcSEcCtD
Norethindrone—Dyspepsia—Risedronate—Paget's disease of bone	0.00539	0.00539	CcSEcCtD
Norethindrone—Nausea—Etidronic acid—Paget's disease of bone	0.00532	0.00532	CcSEcCtD
Norethindrone—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00532	0.00532	CcSEcCtD
Norethindrone—Oedema—Zoledronate—Paget's disease of bone	0.00532	0.00532	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00529	0.00529	CcSEcCtD
Norethindrone—Fatigue—Risedronate—Paget's disease of bone	0.00528	0.00528	CcSEcCtD
Norethindrone—Insomnia—Pamidronate—Paget's disease of bone	0.00527	0.00527	CcSEcCtD
Norethindrone—Somnolence—Pamidronate—Paget's disease of bone	0.00518	0.00518	CcSEcCtD
Norethindrone—Skin disorder—Zoledronate—Paget's disease of bone	0.00517	0.00517	CcSEcCtD
Norethindrone—Dyspepsia—Pamidronate—Paget's disease of bone	0.00513	0.00513	CcSEcCtD
Norethindrone—Dizziness—Alendronate—Paget's disease of bone	0.00505	0.00505	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00503	0.00503	CcSEcCtD
Norethindrone—Fatigue—Pamidronate—Paget's disease of bone	0.00502	0.00502	CcSEcCtD
Norethindrone—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00501	0.00501	CcSEcCtD
Norethindrone—Urticaria—Risedronate—Paget's disease of bone	0.00487	0.00487	CcSEcCtD
Norethindrone—Vomiting—Alendronate—Paget's disease of bone	0.00485	0.00485	CcSEcCtD
Norethindrone—Abdominal pain—Risedronate—Paget's disease of bone	0.00484	0.00484	CcSEcCtD
Norethindrone—Rash—Alendronate—Paget's disease of bone	0.00481	0.00481	CcSEcCtD
Norethindrone—Insomnia—Zoledronate—Paget's disease of bone	0.00481	0.00481	CcSEcCtD
Norethindrone—Dermatitis—Alendronate—Paget's disease of bone	0.00481	0.00481	CcSEcCtD
Norethindrone—Headache—Alendronate—Paget's disease of bone	0.00478	0.00478	CcSEcCtD
Norethindrone—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00476	0.00476	CcSEcCtD
Norethindrone—Somnolence—Zoledronate—Paget's disease of bone	0.00473	0.00473	CcSEcCtD
Norethindrone—Dyspepsia—Zoledronate—Paget's disease of bone	0.00468	0.00468	CcSEcCtD
Norethindrone—Abdominal pain—Pamidronate—Paget's disease of bone	0.0046	0.0046	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00459	0.00459	CcSEcCtD
Norethindrone—Fatigue—Zoledronate—Paget's disease of bone	0.00459	0.00459	CcSEcCtD
Norethindrone—Nausea—Alendronate—Paget's disease of bone	0.00453	0.00453	CcSEcCtD
Norethindrone—Hypersensitivity—Risedronate—Paget's disease of bone	0.00451	0.00451	CcSEcCtD
Norethindrone—Asthenia—Risedronate—Paget's disease of bone	0.00439	0.00439	CcSEcCtD
Norethindrone—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Norethindrone—Pruritus—Risedronate—Paget's disease of bone	0.00433	0.00433	CcSEcCtD
Norethindrone—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00429	0.00429	CcSEcCtD
Norethindrone—Urticaria—Zoledronate—Paget's disease of bone	0.00422	0.00422	CcSEcCtD
Norethindrone—Abdominal pain—Zoledronate—Paget's disease of bone	0.0042	0.0042	CcSEcCtD
Norethindrone—Asthenia—Pamidronate—Paget's disease of bone	0.00418	0.00418	CcSEcCtD
Norethindrone—Pruritus—Pamidronate—Paget's disease of bone	0.00412	0.00412	CcSEcCtD
Norethindrone—Dizziness—Risedronate—Paget's disease of bone	0.00405	0.00405	CcSEcCtD
Norethindrone—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00392	0.00392	CcSEcCtD
Norethindrone—Vomiting—Risedronate—Paget's disease of bone	0.00389	0.00389	CcSEcCtD
Norethindrone—Rash—Risedronate—Paget's disease of bone	0.00386	0.00386	CcSEcCtD
Norethindrone—Dermatitis—Risedronate—Paget's disease of bone	0.00386	0.00386	CcSEcCtD
Norethindrone—Dizziness—Pamidronate—Paget's disease of bone	0.00385	0.00385	CcSEcCtD
Norethindrone—Headache—Risedronate—Paget's disease of bone	0.00384	0.00384	CcSEcCtD
Norethindrone—Asthenia—Zoledronate—Paget's disease of bone	0.00382	0.00382	CcSEcCtD
Norethindrone—Pruritus—Zoledronate—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Norethindrone—Vomiting—Pamidronate—Paget's disease of bone	0.0037	0.0037	CcSEcCtD
Norethindrone—Rash—Pamidronate—Paget's disease of bone	0.00367	0.00367	CcSEcCtD
Norethindrone—Dermatitis—Pamidronate—Paget's disease of bone	0.00367	0.00367	CcSEcCtD
Norethindrone—Headache—Pamidronate—Paget's disease of bone	0.00365	0.00365	CcSEcCtD
Norethindrone—Nausea—Risedronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Norethindrone—Dizziness—Zoledronate—Paget's disease of bone	0.00352	0.00352	CcSEcCtD
Norethindrone—Nausea—Pamidronate—Paget's disease of bone	0.00346	0.00346	CcSEcCtD
Norethindrone—Vomiting—Zoledronate—Paget's disease of bone	0.00338	0.00338	CcSEcCtD
Norethindrone—Rash—Zoledronate—Paget's disease of bone	0.00335	0.00335	CcSEcCtD
Norethindrone—Dermatitis—Zoledronate—Paget's disease of bone	0.00335	0.00335	CcSEcCtD
Norethindrone—Headache—Zoledronate—Paget's disease of bone	0.00333	0.00333	CcSEcCtD
Norethindrone—Nausea—Zoledronate—Paget's disease of bone	0.00316	0.00316	CcSEcCtD
